Skip to main content
Caplight Logo









Nova Biochem

Nova Biochem

Private
NottinghamEnergy & Sustainabilityhttps://nova-biochem.com/

Last Round

Seed

Oct 31, 2025

Total Funding Raised

$8.81M

Company Overview

Nova Biochem is a chemical technology company that transforms industrial side-streams from the pulp and paper industry into high-value circular chemicals intended to replace those made from crude oil.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Circular Economy, Clean Manufacturing

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

bio-aromatic chemicalslignin valorizationwaste to valuehydrothermal processcircular chemicalspetrochemical alternativesdrop-in replacementssupercritical waterbiorefinerycarbon-negative chemicalssustainable chemicalsligninbioplasticsbio-based adhesivesbio-based resins

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nova Biochem Comparables

Compare Nova Biochem with similar companies based on industry and business-model similarity.

Nova Biochem comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bloom Biorenewables
84%
BioBTX
77%
Lignin Industries
71%

Nova Biochem Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 31, 2025
GrantSep 1, 2025

Key People

Founding team and executive leadership

Alexander Novitskiy

Chief Executive Officer

Executive Team

Nova Biochem Investors

Notable investors and investment history

Nova Biochem investors
InvestorRounds
TSP VenturesPre Seed, Seed
Circular Bio-based Europe Joint UndertakingGrant
Archipelago VenturesSeed
Circulate CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2025

    Secured $9M from Circular Bio-based Europe Joint Undertaking.

Nova Biochem Filings

Explore SEC and related filing metadata, where available.

Nova Biochem filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nova Biochem's valuation, stock price, and market status.

Is Nova Biochem a public or private company?

Nova Biochem is a private company.

What is the current stock price of Nova Biochem?

Nova Biochem is a private company with no public stock price. No recent secondary market data is available.

How much is Nova Biochem worth (valuation)?

Valuation information for Nova Biochem is not publicly available.

Can I buy Nova Biochem stock?

Nova Biochem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nova Biochem's last funding round?

Funding round information for Nova Biochem is not publicly available.

Who are the main investors in Nova Biochem?

Investor information for Nova Biochem is not publicly disclosed.

Will Nova Biochem IPO soon?

No public IPO plans have been announced for Nova Biochem.

How can I track Nova Biochem secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nova Biochem's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNottingham
Year Founded2023
Last FundingOct 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?